DEA Will (Possibly) Allow More Federal Grow Applicants

Share this with your friends

Ladybud has been following Dr. Suzanne Sisley’s research attempts for multiple years. From the end of her study at the University of Arizona to her recent lawsuits related to the quality of federally provided cannabis, Dr. Sisley’s career has pushed the boundaries of what was medically acceptable and legally allowable for cannabis research in the United States.

As of Monday, August 26, 2019, her pending lawsuit against the federal government seems to have been resolved. As you likely recall, Dr. Sisley took great issue with the low quality of cannabis provided by federal growers at the University of Mississippi, as well as the intermingling of strains and the inability to request specific cannabinoid profiles for research purposes.

In response to her lawsuit, the Drug Enforcement Administration (DEA) announced that they have created rules that, if approved, will level the federal playing field for growing cannabis for research purposes. In theory, that should mean that researchers will soon have access to cannabis grown by more skillful growers and that will better fit their needs as researchers. Growers and facilities will have the potential ability to file an application to grow cannabis for federal research purposed.

Higher-quality cannabis and better control of cannabinoid profiles for medical testing will inevitably lead to more accurate and promising research. Of course, simply announcing the development of new potential policies is not the same thing as rolling them out. It could be months or even years before new growers get to apply to provide cannabis for federal research purposes.

It is important for activists to remain interested in the topic and to push for federal action that will support ongoing academic and medical research into the potential of cannabis itself and its various cannabinoids. Only with better cannabis can medical research truly show the potential uses and benefits of whole-plant cannabis and the individual cannabinoids.

For previous Ladybud articles about Dr. Sue Sisley, click here.